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Discounting the duration of bolus exposure
in impedance testing underestimates acid
reflux
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Abstract
Background: Combined impedance-pH testing (MII) allows for detection of reflux episodes regardless of pH.
However impedance-based diagnosis of reflux may not routinely account for duration of the reflux episode.
We hypothesize that impedance testing may be less sensitive than pH-testing in detecting acid reflux off therapy
as a result of discounting duration of exposure.
Methods: Baseline characteristics and reflux parameters of MII studies performed off-anti-secretory medications
were analyzed. Studies on acid suppressive medication and those with recording times less than 20 h or low
baseline impedance were excluded.
Results: A total of 73 consecutive MII studies were analyzed of which 31 MII studies had elevated acid exposure
while 16 were abnormal by impedance criteria. MII testing off-therapy was more likely to be abnormal by
pH criteria (percent time pH < 4) than impedance criteria (total reflux):[42 vs 22 % (p =0.02)]. Acid exposure
(percent time pH < 4) identified more studies as abnormal than MII-detected acid reflux episodes [42 vs 34 %
(p < 0.01)]. Mean acid clearance time (pH-detected) was significantly longer than median bolus clearance time
(impedance-detected) in the total [98.7 s vs 12.6 s (p < 0.01)], upright [58.6 s vs 13.1 s (p < 0.01)], and recumbent positions
[136.7 s vs 14.2 s (p < 0.01)] with the greatest difference seen in the recumbent position. The mean ratio of mean acid
clearance time (pH-detected) and the median bolus clearance time (impedance-detected) was significantly higher in the
recumbent position compared to the upright position [11. vs 5.3 (p = 0.01)].
Conclusion: Ambulatory impedance testing underestimates acid reflux compared to esophageal acid exposure by




Current treatment paradigms for GERD are based on
the objective demonstration of pathologic acid exposure
by reflux testing or endoscopic evidence of mucosal dis-
ease [1]. Conventional ambulatory esophageal pH moni-
toring defines reflux as an abrupt drop in distal
esophageal pH below 4 with pathological acid exposure
defined by a composite of 6 variables of which acid ex-
posure time (percentage time with pH <4) is the single
most useful and reproducible index that correlates with
disease severity and treatment response [2–4]. Com-
bined impedance-pH testing (MII) offers a potentially
more precise means of measuring reflux by allowing dif-
ferentiation of reflux from swallow-induced pH changes
that may result from consumption of foods and liquids
with pH < 4 as well as identifying non-acid reflux [5, 6] .
However pathological reflux in MII studies is defined
by the number of impedance-detected reflux events and
their temporal association with symptoms and may not
routinely account for the duration of the reflux episode
[7, 8]. Furthermore software analysis can be set to only
analyze reflux events that have detected by impedance,
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thereby ignoring those events that have been deemed to
be reflux by pH characteristics alone.
The duration of esophageal acid exposure measured
by pH has been previously demonstrated to be longer
than bolus duration determined by impedance [7]. We
hypothesize that impedance testing may be less sensitive
than pH testing in detecting acid reflux as it discounts
the duration of bolus exposure and that this effect may
be particularly significant in the supine position and
under-diagnose pathological reflux in those not on acid
suppressing medications.
Methods
MII studies (Sandhill Scientific, Highlands Ranch, CO,
USA) that were performed off-anti-secretory medica-
tions at Mayo Clinic, Rochester from 1 Jan 09 to 31 Mar
10 were retrospectively analyzed. MII studies were per-
formed for the definitive diagnosis of pathological reflux
in patients with refractory reflux symptoms, extra-
esophageal reflux symptoms and for assessment prior to
fundoplication. Ambulatory 24-h testing was performed
after an overnight fast. The MII-pH catheter consists of
a 2.1-mm polyurethane catheter incorporating 6 imped-
ance segments and 1 pH-measuring electrode at 5 cm
above the lower esophageal sphincter. Proton pump in-
hibitors and histamine-2 receptor antagonists were dis-
continued for 7 and 3 days prior to the test respectively.
Patients undergoing testing are encouraged to maintain
normal activities and sleep schedule. Post-test calibration
of antimony pH probes is routinely performed to correct
for pH drift [9]. Studies performed on acid suppressive
medication, those with recording times less than 20 h
and those with low baseline impedance reducing the
sensitivity for detecting reflux events were excluded
from analysis.
At the end of the 24 h recording period, data was
transferred and analyzed manually using dedicated soft-
ware (Bioview Analysis; Sandhill Scientific). All tracings
were manually reviewed by the investigator [10]. Reflux
events based on retrograde bolus events were initially
identified by the analysis software and false positive
events were deleted. Baseline characteristics as well as
reflux testing parameters were analyzed including the
following parameters - (1) the percentage of total time
that the pH was < 4, (2) the percentage of upright time
that the pH was <4, (3) the percentage of supine time
that the pH was < 4, (4) the number of reflux events, (5)
the number of reflux events longer than 5 min, and (6)
the longest reflux event, (7) total number of impedance-
detected reflux episodes (8) impedance-detected reflux
episodes in the recumbent position (9) impedance-
detected reflux episodes in the supine position. pH indi-
ces were compared with the corresponding impedance
indices in the total, upright and recumbent positions. In
particular, the reflux clearance characteristics were
analyzed by comparing the mean acid clearance time
(pH-detected) with the median bolus clearance time
(impedance-detected) in the total, upright and recum-
bent position. The ratio of the mean acid clearance
time (pH-detected) and the median bolus clearance
time (impedance-detected) was analyzed in the up-
right and recumbent position to compare the magni-
tude of the discrepancy between pH and impedance
in the upright and recumbent positions.
Distal esophageal acid exposure can be quantified
using the percentage time pH < 4 or DeMeester score.
MII studies were categorized as abnormal by acid expos-
ure criteria if the percentage of total time that the pH
was < 4 was 4.2 % or more [11]. MII studies were catego-
rized as abnormal by impedance criteria if they had
elevated number of impedance-detected reflux episodes
(73 or more) [7]. The proportion of MII that were posi-
tive by impedance criteria was compared to the propor-
tion of MII that were positive by acid exposure. In
addition, the MII studies were separately categorized by
acid exposure criteria on the basis of an elevated
DeMeester score (14.7 or more) and the proportion of
abnormal studies were compared with the proportion of
abnormal MII by impedance criteria [11].
Baseline continuous data was compared using the
2-sample t test or the Wilcoxon rank-sum test de-
pending on the data normality. Baseline categoric data
was compared using the chi-squared test. Statistical
analysis was performed using SPSS software (Statis-
tical Package for the Social Sciences, Chicago, Illnois,
USA). Statistical significance was defined as p value
<0.05. This study was approved by Mayo Clinic Insti-
tutional Review Board. The waiver of the requirement
to obtain informed consent was approved in accord-
ance with 45 CFR 46.116.
Results
A total of 73 consecutive MII studies performed off anti-
secretory medication were analyzed. Of these, 50 were
performed in females and the median age was 50 years
(range 25–78). Baseline MII results are shown (Table 1).
Thirty one MII studies had elevated acid exposure while
16 were abnormal by impedance criteria.
Fifteen and thirty one studies had elevated acid expos-
ure in the upright and recumbent position respectively.
Fifteen and thirty one studies had increased impedance-
detected reflux events in the upright and recumbent
position respectively.
MII testing off-therapy was more likely to be abnormal
by pH criteria (percent time pH < 4) than impedance cri-
teria (total reflux):42 vs 22 % (p =0.02). Acid exposure
(percent time pH < 4) identified more abnormal studies
than MII detected reflux episodes: 42 vs 34 % (p <0.01).
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Testing off therapy was more likely to be abnormal by
DeMeester score than impedance criteria (total reflux):
41.1 vs 21.9 % (p = 0.01). The median longest episode
detected by pH was significantly longer than the longest
episode detected by impedance: 4.8 (0.1, 96.5) vs 3.4
(0.2, 161.4) minutes (p <0.01). The median total episodes
of reflux detected by pH was significantly fewer than
impedance-detected reflux episodes: 27.2 (1.1, 122.7) vs
41 (6,162) p < 0.01.
We further analyzed the reflux clearance characteris-
tics by comparing pH versus impedance (Table 2). The
mean acid clearance time (pH-detected) was significantly
longer than the median bolus clearance time (imped-
ance-detected) in the total, upright and recumbent
positions: 98.7 s vs 12.6 s (p < 0.01), 58.6 s vs 13.1 s
(p < 0.01), 136.7 s vs 14.2 s (p < 0.01) with the greatest
difference seen in the recumbent position. The mean
ratio of mean acid clearance time (pH-detected) and
the median bolus clearance time (impedance-detected)
was significantly higher in the recumbent position
compared to the upright position: 11. vs 5.3 (p =
0.01). This indicates that the difference between pH
detected acid clearance and impedance-detected bolus
clearance is greater in the recumbent position com-
pared to the upright position.
Discussion
Standard pH- only ambulatory esophageal monitoring
has been largely replaced with combined impedance-pH
monitoring on the premise that impedance provides a
diagnostic gain by detecting non-acid reflux and improv-
ing symptom reflux correlation during testing on therapy
[12–14]. Impedance monitoring has expanded on pH-
metry with detection of reflux of liquid irrespective of
acidity and gas which has enabled detection of reflux on
anti-secretory therapy as well as characterization of non-
Table 1 Baseline MII results
Parameters Median Range (Min, Max)
Duration of analysis Duration of analysis total (hours:min) 21:22 (20:01, 24:22)
Duration of analysis upright (hours:min) 12:17 (2:35, 18:25)
Duration of analysis recumbent (hours:min) 8:59 (2:50, 20:47)
Median gastric pH 2.2 (1.6,3.7)a
Esophageal acid exposure Percentage time total ph < 4 (%) 1.6 (0,17.3)
Percentage time upright ph < 4 (%) 1.9 (0,24.4)
Percentage time recumbent ph < 4 (%) 0.8 (0,23.3)
Episodes Over 5 min 0.0 (0,11.1)
Longest Episode/min 4.8 (1,96.5)
Total Episodes 27.2 (1.1, 122.7)
Demeester score 5.8 (0.8,59.1)
Impedance Baseline impedance/Ω 1614 (588,5420)
no. of impedance events (total) 41 (6,162)
no. of impedance events (upright) 37 (2,149)
no. of impedance events (recumbent) 5 (0,45)
longest impedance detected episode/min 3.4 (0.2,161)
Acid reflux 21 (0,88)
Non-acid reflux 17 (1,159)
Bolus exposure (%) 1.3 (0.1, 21.2)
aGastric pH data missing in 27 studies
Table 2 Temporal characteristics of acid clearance versus impedance detected bolus clearance
Parameters Median Range (Min, Max)
Esophageal acid exposure Mean Acid Clearance time - total (sec) 66 (7,1257)
Mean Acid Clearance time - upright (sec) 48 (0,179)
Mean Acid Clearance time - recumbent (sec) 44 (0,1257)
Impedance Median Bolus Clearance Time-total/sec 12 (3,31)
Median Bolus Clearance Time-upright/sec 12 (5,37)
Median Bolus Clearance Time- recumbent/sec 10 (0,96)
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reflux conditions such as rumination and supragastric
belching [15, 16].
However, impedance-based categorization of reflux
based on normative data has not been validated by
outcome-based studies and recent outcome-based
studies suggest impedance parameters may not be as
predictive as conventional acid exposure in predicting
treatment response [17, 18]. The true relevance of
negative impedance studies performed on antisecre-
tory therapy without prior confirmation of reflux is
also unclear.
Our study demonstrates that in testing off therapy, im-
pedance underestimates reflux compared to esophageal
acid exposure resulting in a decreased proportion of
studies positive for pathological reflux. Both acid expos-
ure (pH <4) as well as DeMeester score were more likely
to result in a positive test than impedance detected re-
flux episodes. This is despite the increased detection of
reflux episodes by impedance compared to conventional
pH criteria.
This may be due to the failure of impedance to ac-
count for the prolonged period of mucosal contact with
each acid reflux episode particularly in the recumbent
position. The mean acid clearance time (pH-detected)
was significantly longer than the median bolus clearance
time (impedance-detected) in all positions. Furthermore,
the median longest episode was significantly longer with
pH testing compared to impedance. These findings indi-
cate that impedance underestimates the duration of
bolus exposure to esophageal mucosa compared to pH.
These differences are more marked in the recumbent
position since the ratio of pH detected mean acid clear-
ance time and impedance detected median bolus clear-
ance time was significantly higher in the recumbent
position compared to the upright position.
These findings are consistent with the two-step acid
clearing mechanism. Esophageal acid clearance is initiated
by peristalsis and completed following neutralization by
swallowed alkaline saliva. Impedance returns to baseline
values with clearance of the majority of the acid bolus by
peristalsis but pH detects the small amount of residual
acid that persists until neutralization by alkaline saliva
[19]. This difference is more marked in the recumbent
period where the much longer acid reflux events are not
adequately reflected by the impedance measures. This
is likely due to the lack of buffering by alkaline saliva
as the production of saliva is reduced at night. De-
creased swallowing frequency, salivary production and
decreased delivery to the distal esophagus during
sleep retards neutralization of esophageal pH after
acid reflux [20]. So, the pH does not normalize as quickly
due to the decreased saliva even though bolus clearance
by impedance is almost equal in the upright and recum-
bent position as demonstrated in this study. Hence in
studies performed off medication, the pH component ap-
pears to be more reliable particularly in the recumbent
position. Studies with low baseline impedance that could
confound analysis by lowering the sensitivity of impedance
detection of reflux were excluded hence this could not
account for the results.
Nocturnal acid reflux can induce sleep disturbances
and decrease health-related quality of life [21, 22].
Furthermore nocturnal acid reflux has been associated
with more severe esophageal mucosal damage, such
as peptic stricture and adenocarcinoma and an in-
creased risk of pulmonary complications [23, 24].
Under-diagnosis of reflux may have significant public
health implications.
In the absence of acid suppression, clinicians need to
pay more attention to pH parameters than impedance.
Perhaps impedance-based diagnostic criteria need to be
revised to accurately reflect duration of acid contact
especially in the recumbent position. Current analysis
software may calculate impedance-detected bolus expos-
ure. Although normative data on impedance-derived
bolus measures is available and could potentially be
incorporated into impedance-based diagnosis of reflux,
emerging studies suggest that impedance parameters
may not be as predictive as conventional acid exposure
in predicting treatment response [17, 18]. Future studies
could compare pH- and impedance-detected bolus
exposure to assess the impact of incorporating impedance-
detected bolus exposure on the impedance-based diagnosis
of reflux.
The findings may have implications for testing on
therapy that merit further study. Patients with pro-
longed non-acid reflux events below the current
impedance-based diagnostic thresholds may still have
clinically significant reflux events that could account
for symptoms even if they may not be as injurious to
the mucosa.
There are shortcomings to this study. This is a retro-
spective review. Recumbency was also assumed to be a
surrogate for sleep when saliva production in decreased
though differences in reflux characteristics of recumbent-
awake and recumbent-asleep periods are not routinely
measured in clinical practice [25].
Conclusion
In conclusion, impedance underestimates acid reflux
compared to esophageal acid exposure with testing
off therapy. This may be due to the failure of imped-
ance to account for the prolonged period of mucosal
contact with each acid reflux episode particularly in
the recumbent position. Clinicians should continue to
rely on standard pH parameters for assessment of
reflux in those patients being studied off acid sup-
pressive medications.
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